Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on Dec 15, 2025 - 3:59PM >>   ABB 5276.1 [ 0.03 ]ACC 1780 [ 0.47 ]AMBUJA CEM 554 [ 1.09 ]ASIAN PAINTS 2780.2 [ 0.53 ]AXIS BANK 1284.95 [ -0.10 ]BAJAJ AUTO 8915.3 [ -1.10 ]BANKOFBARODA 285.05 [ 0.19 ]BHARTI AIRTE 2071.95 [ -0.55 ]BHEL 282.55 [ -1.00 ]BPCL 366.75 [ 0.53 ]BRITANIAINDS 6037.5 [ 2.07 ]CIPLA 1507.25 [ -0.66 ]COAL INDIA 384.45 [ 0.30 ]COLGATEPALMO 2165.9 [ 0.27 ]DABUR INDIA 497.25 [ 0.53 ]DLF 697 [ -0.35 ]DRREDDYSLAB 1277.4 [ -0.18 ]GAIL 169.85 [ -0.56 ]GRASIM INDS 2820.8 [ -0.57 ]HCLTECHNOLOG 1683.8 [ 0.68 ]HDFC BANK 994.6 [ -0.56 ]HEROMOTOCORP 5953 [ -0.10 ]HIND.UNILEV 2292 [ 1.37 ]HINDALCO 847.7 [ -0.54 ]ICICI BANK 1365.2 [ -0.06 ]INDIANHOTELS 729.3 [ -0.75 ]INDUSINDBANK 851.3 [ 0.66 ]INFOSYS 1607.05 [ 0.52 ]ITC LTD 402.3 [ 0.45 ]JINDALSTLPOW 1030 [ 0.04 ]KOTAK BANK 2180.5 [ 0.19 ]L&T 4090.95 [ 0.42 ]LUPIN 2086.15 [ -1.32 ]MAH&MAH 3607.55 [ -1.94 ]MARUTI SUZUK 16374.25 [ -0.89 ]MTNL 36.14 [ -1.90 ]NESTLE 1241.75 [ 0.29 ]NIIT 90.33 [ 2.38 ]NMDC 78.46 [ 0.71 ]NTPC 323.85 [ -0.37 ]ONGC 235.35 [ -1.13 ]PNB 118.7 [ 0.76 ]POWER GRID 262.3 [ -0.49 ]RIL 1556.05 [ 0.00 ]SBI 967.15 [ 0.44 ]SESA GOA 550 [ 1.19 ]SHIPPINGCORP 222.15 [ -1.46 ]SUNPHRMINDS 1794.2 [ -0.01 ]TATA CHEM 765.75 [ 0.90 ]TATA GLOBAL 1153.95 [ 0.40 ]TATA MOTORS 347.1 [ -0.10 ]TATA STEEL 172.8 [ 0.52 ]TATAPOWERCOM 381.6 [ -0.08 ]TCS 3230.4 [ 0.32 ]TECH MAHINDR 1576.7 [ -0.15 ]ULTRATECHCEM 11695.2 [ -0.25 ]UNITED SPIRI 1441.4 [ -0.39 ]WIPRO 261.7 [ 0.44 ]ZEETELEFILMS 93.75 [ -0.53 ] BSE NSE
You can view the entire text of Notes to accounts of the company for the latest year

BSE: 524743ISIN: INE771F01041INDUSTRY: Medical Equipment & Accessories

BSE   ` 45.33   Open: 46.36   Today's Range 45.04
46.70
-0.30 ( -0.66 %) Prev Close: 45.63 52 Week Range 40.95
124.20
Year End :2025-03 

12. Provisions, Contingent Liabilities and Contingent Assets

12.1 Provisions

A provision is recognized when the Company has a present obligation (Legal or constructive) as a result
of a past event, it is probable that an outflow of resources will be required to settle the obligation, and a
reliable estimate can be made of the amount of the obligation.

12.2 Contingent Liabilities

Contingent liabilities are disclosed when there is a possible obligation arising from past events, the
existence of which will be confirmed only by the occurrence or non-occurrence of one or more uncertain
future events not wholly within the control of the Company, or a present obligation that is not recognized
because it is not probable that an outflow of resources will be required, or the amount cannot be reliably
estimated.

12.3 Contingent Assets

Contingent assets are disclosed where an inflow of economic benefits is probable. However, when the
realization of income is virtually certain, then the related asset is no longer considered contingent and
recognized as an asset.

13. Financial Instruments

Financial instruments are recognized when the Company becomes a party to the contractual provisions of
the instrument. They are initially measured at fair value. Transaction costs that are directly attributable to the
acquisition or issue of financial assets and financial liabilities (other than financial assets and liabilities at fair
value through profit or loss) are added to or deducted from the fair value of the financial assets or financial
liabilities, as appropriate, on initial recognition.

14. Financial Assets

Financial assets include trade receivables, investments, cash and cash equivalents, and other financial assets.
The classification is based on the business model in which a financial asset is managed and its contractual
cash flow characteristics.

Amortized Cost: Assets held to collect contractual cash flows where the cash flows are solely payments of
principal and interest are measured amortized cost.

Fair Value Through Other Comprehensive Income (FVOCI): Assets held to collect cash flows and sell the
assets are measured at FVOCI. Fair Value Through Profit or Loss (FVTPL): Assets that do not meet the criteria
for amortized cost or FVOCI are measured at FVTPL.

Impairment is recognized using the expected credit loss (ECL) model as per Ind AS 109. The simplified
approach is applied to trade receivables.

15. Financial Liabilities and Equity Instruments

15.1 Financial Liabilities

Financial liabilities are initially recognized at fair value and subsequently measured at amortized cost
using the effective interest rate (EIR) method. These include trade payables, borrowings, and other
financial liabilities.

15.2 Equity Instruments

An equity instrument is any contract that evidences a residual interest in the assets of an entity after
deducting all of its liabilities. Equity instruments issued by the Company are recognized at the proceeds
received, net of direct issue costs.

16. Earnings Per Share (EPS)

The Company presents basic and diluted earnings per share (EPS) for its equity shares.

Basic EPS is calculated by dividing the net profit or loss for the period attributable to equity shareholders by
the weighted average number of equi shares outstanding during the period.

Diluted EPS is computed by adjusting the weighted average number of equity shares to assume conversion
of all dilutive potential equity shares.

17. Cash Flow Statement

The Company prepares the cash flow statement using theindirect method, as per Ind AS 7, “Statement of
Cash Flows.” Cash and cash equivalents include cash on hand, balances with banks, and highly liquid
investments with original maturities of three months or less.

18. Dividends

Final dividends on shares are recorded as a liability on the date of approval by the shareholders. Interim
dividends, if any, are recorded as a liability on the date of declaration by the Board of Directors.

19. Foreign Currency Translation

The financial statements of foreign operations are translated into INR as follows:

Assets and liabilities: closing rate at the reporting date. Income and expenses: average exchange rate for
the period.

All resulting exchange differences are recognized in other Comprehensive Income (OCI) and accumulated
in Foreign Currency Translation Reserve.

19.1. Functional and Presentation Currency

The financial statements are presented in Indian Rupees (INR), which is the functional and presentation
currency of the Company. All financial information presented in INR has been rounded off to the nearest
lakh, unless otherwise stated.

20. Basis of Consolidation and Equity Accounting

The consolidated financial statements incorporate the financial statements of the Company and its
subsidiaries. Control is achieved when t Company:

1. Has power over the investee;

2. Is exposed, or has rights, to variable returns from its involvement with the investee; and

3. Has the ability to use its power to affect its returns.

4. The financial statements of all subsidiaries are prepared using uniform accounting policies. Intra-group
balances, transactions, and unrealize profits or losses are eliminated in full

Investments in associates or joint ventures are accounted for using the equity method as per Ind AS 28.
The investment is initially recognized at cost and adjusted thereafter for the post-acquisition change in the
Company's share of net assets of the investee.

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or Liabilities.

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either
directly (i.e. as prices) or indirectly (i.e. derived from prices).

Level 3 - Inputs for the assets or liabilities that are not based on observable market data (unobservable inputs).

There were no transfers between the levels during the year.

Valuation processes

The finance department of the Company performs the valuations of financial assets and liabilities required for financial
reporting purposes, including level 3 fair values. The fair valuation of level 1 and level 2 classified assets and liabilities are
readily available from the quoted prices in the open market and rates available in secondary market respectively. The
valuation method applied for various financial assets and liabilities are as follows -

Quoted price in the primary market (NAV) considered for the fair valuation of the current investment.

The carrying amounts of trade receivable, cash and bank balances, other financial assets and liabilities,
borrowings are considered to be the same as their fair value due to their short-term nature.

NOTE NO. : 33 -Balance Confirmations

Some of the balances of and current trade payables are subject to confirmation and reconciliation of any.

NOTE NO. : 34- Previous Years Re-grouped

Figures for previous periods have been regrouped / reclassified wherever considered necessasry.

NOTE NO. : 35- Struck Off Companies

During the year, the Company has no transactions with struck off company.

NOTE NO. : 36- Segment Reporting

Since the company operates in single segment, Segment Reporting does not apply to the company.

NOTE NO. : 37- Information about major customers

The company had revenue from operations for the year ended March 31, 2025, consisting of one major customer
constituting 90.20% and 30.86% of total debtors respectively at the year and the company.

NOTE NO. : 38- Additional disclosure with respect to amendments to Schedule III

1. No proceedings have been initiated or are pending against the Company for holding any benami
property under the Prohibition of Benami Property Transactions Act, 1988 (as amended) and rules
made thereunder

2. The Company does not have any such transaction which is not recorded in the books of accounts that
has been surrendered or disclosed as income during the year in the tax assessments under the
Income Tax Act, 1961

3. The Company has not been declared a wilful defaulter by any bank or financial institution or other
lender (as defined under the Companies Act, 2013) or consortium thereof, in accordance with the
guidelines on wilful defaulters issued by the Reserve Bank of India

4. The Company does not have any charges or satisfaction which is yet to be registered with Registrar
of Companies (ROC) beyond the statutory period

5. The Company has complied with the number of layers prescribed under the Companies Act, 2013

6. The Company does not have any transaction with companies struck off under section 248 of the
Companies Act, 2013 or section 560 of the Companies Act, 1956 as of and for the year ended
March 31 2024 and March 31 2023

7. The Company has not revalued its Property, Plant, and Equipment, or Intangible assets during the year.

8. The Company has not traded or invested in Crypto Currency or Virtual Currency during the financial
year

9. The Company has not received any fund from any person(s) or entity(ies), including foreign entities
(Funding Party) with the understanding (whether recorded in writing or otherwise) that the Company
shall

a. directly or indirectly lend or invest in other persons or entities identified in any manner
whatsoever by or on behalf of the Funding Party (Ultimate Beneficiaries) or ;

b. provide any guarantee, security or the like on behalf of the ultimate beneficiaries.

NOTE NO. 39: FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES

The Company's principal financial liabilities comprise trade and other payables. The main purpose of these financial
liabilities is to finance the Company's operations. The Company's principal financial assets and cash and cash
equivalents that derive directly from its operations. The Company is exposed to market risk, credit risk and liquidity
risk. Company's senior management oversees the management of these risks. It is Company's policy that no trading
in derivatives for speculative purposes may be undertaken. The Board of Directors review and agree policies for
managing each of these risks, which are summarised below.

Market risk

Market risk is the risk of any loss in future earnings, in realisable fair value or in future cash flows that may result from
a change in the price of a financial instrument. The value of a financial instrument may change as a result of change
in the interest rates, foreign currency exchange rates, liquidity and other market changes. Future specific market
movements cannot be normally predicted with reasonable accuracy.

(i) Interest rate sensitivity - Interest rate risk is the risk that the fair value or future cash flows of a financial

instrument will fluctuate because of changes in market interest rates. - Company does not have exposure to the
risk of changes in market interest rates.

- Company does not have exposure to the risk of changes in market interest rates.

Foreign currency risk - The Company has a portion of the business which is transacted in foreign
currencies. The fluctuations in foreign currency exchange rates may have impact on the income statement
and equity. Company's exposure to the risk of changes in foreign exchange rates relates primarily to the
Company's operating activities. The Company is exposed to foreign exchange risk arising from foreign
currency receivables and payables.

Liquidity risk

Liquidity risk is defined as the risk that the Company will not be able to settle or meet its obligations on time or at a
reasonable price. For the Company, liquidity risk arises from obligations on account of financial liabilities - trade
payables and other financial liabilities.

Liquidity risk management

The Company manage its liquidity risk in a manner so as to meet its normal financial obligations without any significant
delay or stress. Such risk is managed through ensuring operational cash flow while at the same time maintaining
adequate cash and cash equivalent position. The management has adopted a policy of managing assets with

Credit Risk

The principal credit risk that the Company is exposed to is non-collection of trade receivables and Late collection of
receivables leading to credit loss. The risk is mitigated by reviewing creditworthiness of the prospective customers
prior to entering into contract and post contracting, through continuous monitoring of collections by a dedicated team.
The Company reviews trade receivables on periodic basis and makes provision for doubtful debts if collection is
doubtful. The Company also calculates the expected credit loss (ECL) for non-collection and for delay in collection
of receivables. The Company makes additional provision if the ECL amount is higher than the provision made for
doubtful debts. In case the ECL amount is lower than the provision made for doubtful debts, the Company retains
the provision made for doubtful debts without any adjustment.

Company's credit period generally ranges from 30 to 180 days

The gross carrying amount of a financial asset is written off (either partially or in full) when there is no
realistic prospect of recovery.

Information about Top customers

The company had revenue from operations for the year ended March 31, 2025, consisting of two major customers
constituting 90.20% and 30.86% of total debtors respectively at the year and the company.

Capital Management

The Company's policy is to maintain a strong capital base so as to maintain investor, creditor and
market confidence and to sustain future development of the business. The Company's objective when
managing capital is to maintain an optimal structure so as to maximise shareholder value.

Capital Structure is as follows -

NOTE NO. 41: FOREGIN CURRENCY EXPOSURE

The Company has adopted Ind AS 116 “Leases” effective 1st April 2019, as notified by the Ministry of Corporate Affairs
(MCA) vide Companies (Indian Accounting Standards), Amendment Rules, 2019, using the modified retrospective
method .Under this simplified Approach, the Company recognized equal amount of right of use asset and lease liability
on the transition date, adjusted by the amount of prepayments pertaining to such leases, carried in the Balance Sheet
on such transition date.

(A) Carrying value of right of use assets at the end of the year

For M/s Bilimoria Mehta & Co. For and on behalf of the Board

Chartered Accountants Fischer Medical Ventures Limited (Formerly known as Fischer Chemic Limited)

FRN: 101490W

CA Prakash Mehta Ravindran Govindan Svetlana Rao Raviwada

Partner Managing Director Whole Time Director

M.No: 030382 DIN : 03137661 DIN : 06899295

Date: May 08 2025 Mr. Vivek Balasubramanian Mr. AravindKumar V

Place of Signature: Mumbai Chief Financial Officer Company Secretary

UDIN: 25030382BMIIIY7523